Mathew Simcock
- Oncology top 10%
- Molecular Biology
- Epidemiology
- Infectious Diseases top 10%
- Hematology top 5%
- Co-authors
- Daniel M. AebersoldJakob PasswegPirus GhadjarUrsula FlückigerParham SendiManuel BattegayAristoteles GiagounidisGert J. Ossenkoppele
- Topics
- Multiple Myeloma Research and Treatments (9 papers)Protein Degradation and Inhibitors (7 papers)Head and Neck Cancer Studies (7 papers)
- Partner nations
- SwitzerlandItalyUnited States
In The Last Decade
Mathew Simcock
45 papers receiving 903 citations
Peers
Comparison fields: 5 of 87
- Oncology 272
- Molecular Biology 214
- Epidemiology 188
- Infectious Diseases 178
- Hematology 164
Countries citing papers authored by Mathew Simcock
This map shows the geographic impact of Mathew Simcock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Simcock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Simcock more than expected).
Fields of papers citing papers by Mathew Simcock
This network shows the impact of papers produced by Mathew Simcock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Simcock. The network helps show where Mathew Simcock may publish in the future.
Co-authorship network of co-authors of Mathew Simcock
This figure shows the co-authorship network connecting the top 25 collaborators of Mathew Simcock. A scholar is included among the top collaborators of Mathew Simcock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew Simcock. Mathew Simcock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 15 | |
| 4 | 1 | |
| 5 | OUTCOMES FOR OLDER PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE STRATUS (MM-010) TRIAL, A SINGLE-ARM, PHASE 3B STUDY | 1 |
| 6 | THE STRATUS (MM-010) TRIAL: A SINGLE-ARM, PHASE 3B STUDY EVALUATING SAFETY AND EFFICACY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA | 1 |
| 7 | 13 | |
| 8 | 26 | |
| 9 | 25 | |
| 10 | 22 | |
| 11 | 54 | |
| 12 | 31 | |
| 13 | 37 | |
| 14 | 32 | |
| 15 | 3 | |
| 16 | 4 | |
| 17 | 30 | |
| 18 | 6 | |
| 19 | 49 | |
| 20 | 33 |
About Mathew Simcock
Mathew Simcock is a scholar working on Otorhinolaryngology, Hematology and Genetics, having authored 46 papers that have together received 926 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (7 papers) and Head and Neck Cancer Studies (7 papers). The work is most often cited by research in Otorhinolaryngology (136 citations), Applied Microbiology and Biotechnology (32 citations) and Hematology (164 citations). Mathew Simcock has collaborated with scholars based in Switzerland, Italy and United States. Frequent co-authors include Daniel M. Aebersold, Jakob Passweg, Pirus Ghadjar, Ursula Flückiger, Parham Sendi, Manuel Battegay, Aristoteles Giagounidis, Gert J. Ossenkoppele, Arnold Ganser and Carlo Aul. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.